Loading
Latest filing published 01 Apr 2022 for Aarti Drugs Limited, €58k.
Seema Harshit Savla, listed as chief executive, appears in our data through filings on Aarti Drugs Limited shares, published by SEBI (PIT + SAST). Over a trading history stretching from 18 May 2021 to 31 March 2022, the count stands at 2 filings.
The open-market record is one-sided, with 1 purchase worth €58k and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2022 to date brings 1 purchase and no sales.
Most recently, on 1 April 2022, the filings show an open-market purchase worth €58k in Aarti Drugs Limited. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations